Extension to a Study on the Efficacy and Safety of Vildagliptin Compared to Metformin in Drug Naive Patients With Type 2 Diabetes

Clinical trial NCT00138567 · COMPLETED

Trial details

NCT number: NCT00138567
Sponsor: Novartis
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Diabetes Mellitus, Type 2

Start date: 2005-01-01
Primary completion: 2006-08-01
Enrollment: 530

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.